Top in hem/onc: Urothelial carcinoma assay, role of social workers in cancer care

A noninvasive assay outperformed standard cytology in detecting urothelial carcinoma, according to a recent study. It was the top story in hematology/oncology last week.

Another top story was about the vital role of social workers in cancer pain management.

Read these and more top stories below in hematology/oncology below:

Noninvasive assay outperforms standard cytology in detection of urothelial carcinoma

A urine-based whole-genome sequencing assay demonstrated high specificity and comparable sensitivity to standard cytology for the detection of urothelial carcinoma, according to study results published in Clinical Cancer Research. Read more.

Social workers play vital role in cancer pain management

Social workers play a critical role in cancer care, helping patients — as well as their families and caregivers — successfully navigate many of the challenges they face. Read more.

Tislelizumab extends OS in advanced NSCLC

Tislelizumab (BGB-A317, BeiGene) prolonged overall survival compared with docetaxel for patients with advanced non-small cell lung cancer, according to topline data released by the agent’s manufacturer. Read more. 

Ipilimumab-nivolumab combination effective, safe for angiosarcoma subset

A quarter of patients with unresectable or metastatic angiosarcoma responded to a combination of ipilimumab (Yervoy, Bristol Myers Squibb) and nivolumab (Opdivo, Bristol Myers Squibb), according to results of an analysis presented at the virtual Society for Immunotherapy of Cancer Annual Meeting. Read more.

Pediatric cancer treatment can cause long-term dental, bone, skin, liver, immunity issues

Late effects of pediatric cancer treatment may not be readily apparent to primary care clinicians or specialists who follow childhood cancer survivors over the long term. Read more.